Sara Melton
About Sara Melton
Sara Melton serves as the Senior Director of Patient Access for Cell and Gene Therapy at Abeona Therapeutics. With extensive experience in the bio-pharmaceutical industry, she focuses on creating solutions for patients and providers while leveraging her strong network and expertise in go-to-market strategies.
Current Role at Abeona Therapeutics
Sara Melton serves as the Senior Director of Patient Access Cell and Gene Therapy at Abeona Therapeutics. She has held this position since 2024, contributing to the organization from Naples, Florida. In her role, she focuses on developing strategies to enhance patient access to cell and gene therapies, ensuring that patients, providers, and payers can navigate the complexities of these innovative treatments.
Previous Experience at Mezzion
Before joining Abeona Therapeutics, Sara Melton worked at Mezzion as the Vice President of Commercial Sales and Marketing from 2021 to 2023. Based in Chicago, Illinois, she was responsible for overseeing sales and marketing initiatives, leveraging her expertise to drive commercial success within the organization.
Professional Background in Marketing and Sales
Sara Melton has a diverse professional background in marketing and sales within the bio-pharmaceutical industry. She held the position of Head of Creative Services, Marketing at Arthrex from 2019 to 2021 in Naples, Florida. Additionally, she served as the Territory Business Manager at Bristol-Myers Squibb from 2001 to 2005 in Michigan and as Senior Director of Sales at Achaogen from 2017 to 2019.
Education and Expertise
Sara Melton earned her Bachelor of Science (BS) degree from Eastern Michigan University. She further advanced her education by obtaining a Master of Business Administration (MBA) from Northwestern University - Kellogg School of Management between 2011 and 2013. Her academic background complements her expertise in go-to-market strategies for rare diseases and specialty products.
Focus on Patient Solutions and Industry Collaboration
Sara Melton is known for her commitment to creating meaningful solutions for patients, providers, and payers. She leverages her extensive network across the bio-pharmaceutical industry to enhance collaboration with National Accounts, Healthcare Providers (HCPs), and Group Purchasing Organizations (GPOs). Her strong background in access and reimbursement dynamics, particularly in cell and gene therapy, cardiology, and oncology, supports her focus on patient access.